| Bioactivity | (R)-Amrubicin ((R)-SM-5887) is an anthracycline that effectively treats lung cancer by intercalating into DNA and inhibiting topoisomerase II activity, which consequently hampers DNA replication as well as RNA and protein synthesis, leading to cell growth inhibition and apoptosis. This compound exhibits superior anti-tumor efficacy compared to traditional anthracycline drugs while lacking the cumulative cardiac toxicity typically associated with this drug class. |
| CAS | 92395-36-3 |
| Formula | C25H25NO9 |
| Molar Mass | 483.47 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
(R)-Amrubicin
CAS: 92395-36-3 F: C25H25NO9 W: 483.47
(R)-Amrubicin ((R)-SM-5887) is an anthracycline that effectively treats lung cancer by intercalating into DNA and inhibi
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.